USP: Excipient Stimuli published for Comments
Recommendation

Wednesday, 6 May 2026 9 .00 - 12.30 h
In the beginning of September, the stimuli document "Proposed Definitions of Excipient Components- Revisions to 2018 Definitions- PF 49(5)" was published on the USP Pharmacopeial Forum website for comments. Comments on this draft can be submitted until 30 November 2023.
This draft is divided into the following chapters:
- Background
- Newly Proposed Definitions
- Appendix
o Original 2018 Definitions
o History of Concomitant Component - References
Table 1 of the paragraph "Newly Proposed Definitions" shows the new proposals for the excipient components and compares them with the previous definitions of the last valid version from 2018. This is followed by examples for each of the definitions. These include five examples each for main components and minor components as well as seven examples for excipient impurities.
The Stimuli document "Proposed Definitions of Excipient Components- Revisions to 2018 Definitions- PF 49(5)" can be viewed and commented on after a one-time registration on the Pharmacopeial Forum website.
Related GMP News
22.04.2026IPEC: Updated Qualification Guide
15.04.2026Ph. Eur.: Updated Guidelines for analytical Balances now available
08.04.2026EMA/CHMP: Updated Guideline on Active Substances published
01.04.2026CMDh/EMA: New Update to Appendix 1 on Nitrosamines
25.03.2026EDQM: How should the Specification of a Substance be Presented in a CEP Application?
25.02.2026EMA: Reflection Paper on Non-Mutagenic Impurities published


